골다공증 약제가 고관절 치환술에 미치는 영향

참고문헌 (59)

1. J. MARK WILKINSON, "Effect of Pamidronate in Preventing Local Bone Loss After Total Hip Arthroplasty, A Randomized, Double-Blind, Controlled Trial", J Bone Miner Res, 16, pp.556~564 (2001)
2. Alain Petit, "Effect of bisphosphonates on the stimulation of macrophages by alumina ceramic particles: A comparison with ultra-high-molecular-weight polyethylene Mater Sci", Mater Med, 17, pp.667~673 (2006)
3. Arun S. Shanbhag, "Use of Bisphosphonates to Improve the Durability of Total Joint Replacements", J Am Acad Orthop Surg, 14, pp.215~225 (2006)
4. Aspenberg P, "Bone allografts pretreated with a bisphosphonate are not resorbed", Acta Orthop Scand, 73, pp.20~23 (2002)
5. Astrand J, "Alendronate did not inhibit instability- induced bone resorption: A study in rats", Acta Orthop Scand, 70, pp.67~70 (1999)
6. Astrand J, "A rat model for testing pharmacologic treatments of pressurerelated bone loss", Clin Orthop Relat Res, 409, pp.296~305 (2003)
7. Astrand J, "Systemic alendronate prevents resorption of necrotic bone during revascularization: A bone chamber study in rats", BMC Musculoskelet Disord, 3, pp.19~ (2002)
8. Berend KR, "Cementless double-tapered total hip.arthroplasty in patients 75 years of age and older", J Arthroplasty, 19, pp.288~295 (2004)
9. Burr DB, "Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs", Bone, 33, pp.960~969 (2003)
10. Carlsson, A.S., "The relationship of bone mass and loosening of the femoral component in total hip replacement", Acta Orthop. Scand, 51, pp.285~ (1980)
11. Carl Talmo, "Nonsurgical Management of Osteolysis: Challenges and Opportunities. Nonsurgical Management of Osteolysis: Challenges and Opportunities", Clinical Orthopaedics and Related Research, 453, pp.254~264 (2006)
12. Chavassieux PM, "Histomorphometric assessment of the longterm effects of alendronate on bone quality and remodeling in patients with osteoporosis", J Clin Invest, 100, pp.1475~1480 (1997)
13. Crozier K, "Alendronate protects against bone loss following THR", Orthop Today, 17, pp.24~ (1997)
14. Dequeker J, "Osteoarthritis and osteoporosis: clinical and research evidence of inverse relationship", Aging Clin Exp Res, 15, pp.426~439 (2003)
15. Dequeker J, "Invers relationship osteoarthritis? osteoporosis: what is the evidence? What are the consequences?", Br J Rheumatol, 35, pp.813~818 (1996)
16. Diana Dan, "Bone loss after total hip arthroplasty", Rheumatol Int, 26, pp.792~798 (2006)
17. Engh CA, "Porous-coated hip replacement", J Bone Joint Surg, 69-B, pp.45~55 (1987)
18. Engh CA, "A quantitative evaluation of periprosthetic bone-remodelling after cementless total hip arthroplasty", J Bone Joint Surg Am, 74-A, pp.1009~1020 (1992)
19. Fischer KJ, "Mechanical evaluation of bone samples following alendronate therapy in healthy male dogs", J Biomed Mater Res B Appl Biomater, 76, pp.143~148 (2006)
20. Gert D. Krischak, "Influence of preoperative mechanical bone quality and bone mineral density on aseptic loosening of total hip arthroplasty after seven years", Clinical Biomechanics, 18, pp.916~923 (2003)
21. Frenkel, "The Effect of Alendronate (FosamaxTM) and Implant Surface on Bone Integration and Remodeling in a Canine Model Sally R. Di Cesare", J Biomed Mater Res (Appl Biomater), 58, pp.645~650 (2001)
22. Goodship AE, "The use of bisphosphonates to inhibit mechanically related bone loss in aseptic loosening of hip prostheses", Trans Orthop Res Soc, 23, pp.2~ (1998)
23. Hierton, C., "Factors associated with early loosening of cemented total hip prostheses", Acta Orthop. Scand, 54, pp.168~173 (1983)
24. Hilding M, "Clodronate prevents prosthetic migration: A randomized radiostereometric study of 50 total knee patients", Acta Orthop Scand, 71, pp.553~557 (2000)
25. Holz, U, "Experience in surface replacement arthroplasty of the hip. Z. Orthop", Ihre Grenzgeb, 118, pp.681~690 (1980)
26. Inoue k, "The effect of aging on bone formation in porous hydroxyapatite: biochemical and histological analysis", J Bone Miner Res, 12, pp.989~994 (1997)
27. 박병문, "심한 골다공증을 동반한 80세 이상 고령의 고관절부 골절 치료에서Zweymu¨ller 무시멘트 스템의 유용성- 시멘트 스템과 대조 연구 -", Hip and Pelvis, 18(5), pp.447~453 (2006), 대한고관절학회
28. Katsuyuki Yamaguchi, "Cyclic therapy with etidronate has a therapeutic effect against local osteoporosis after cementless total hip arthroplasty", Bone, 33, pp.144~149 (2003)
29. Kim HK, "RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis", J Bone Miner Res, 21, pp.1946~1954 (2006)
30. Lai KA, "The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study", J Bone Joint Surg Am, 87(10), pp.2155~2159 (2005)
31. Learmonth ID, "Current thoughts on total hip replacement, Current thoughts on total hip replacement", S Afr Med J, 84(2), pp.88~90 (2004)
32. Little DG, "Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats", J Bone Miner Res, 18, pp.2016~2022 (2003)
33. Looney RJ, "Periprosthetic osteolysis: An immunologist’s update", Curr Opin Rheumatol, 18, pp.80~87 (2006)
34. McCarthy CK, "Quantifying bone loss from the proximal femur after total hip arthroplasty", J Bone Joint Surg Br, 73-B, pp.774~778 (1991)
35. 민병우, "골다공증성 고관절 골절의 약물 치료", Hip and Pelvis, 18(4), pp.405~408 (2006), 대한고관절학회
36. Nixon M, "Does bone quality predict loosening of cemented total hip replacements?", Journal of Bone and Joint Surgery British, 89-B, pp.1303~1308 (2007)
37. Nishii T, "Does alendronate prevent collapse in osteonecrosis of the femoral head?", Clin Orthop Relat Res, 443, pp.273~279 (2006)
38. O’Hara LJ, "Cross-linked olyethylene and bisphosphonate therapy for osteolysis in total hip arthroplasty: A case report", J Orthop Surg, 12, pp.114~121 (2004)
39. "Periprosthetic Osteolysis and Aseptic Loosening of Prostheses in Total Joint Arthroplasty (book chapter), Bisphosphonates in Medical Practice", pp.165~171 (2007), Springer
40. Peter CP, "Effect of alendronate on fracture healing and bone remodeling in dogs", J Orthop Res, 14, pp.74~79 (1996)
41. Roth A, "Press fit fixation of cementless cups: how much stability do we need indeed?", Arch Orthop Trauma Surg, 126(2), pp.77~81 (2006)
42. Salvatore L. Ruggiero, "Osteonecrosis of the Jaws Associated With the Use of Bisphosphonates: A Review of 63 Cases", J Oral Maxillofac Surg, 62, pp.527~534 (2004)
43. Sambrook P, "Osteoporosis", Lancet, 367, pp.2010~2018 (2006)
44. Sambrook P, "What is the relationship between osteoarthritis and osteoporosis?", Baillieres Clin Rheumatol, 11, pp.695~710 (1997)
45. Seebach C, "The influence of bisphosphonates on fracture healing", Orthopade, 36, pp.136~140 (2007)
46. Shanbhag AS, "TheJohn CharnleyAward. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model", Clin Orthop Relat Res, 344, pp.33~43 (1997)
47. Shanbhag AS, "Bisphosphonate therapy for the prevention of osteolysis in total joint replacements", Curr Opin Orthop, 9, pp.81~87 (1998)
48. Sook-Bin Woo, "Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws", Ann Intern Med, 144, pp.753~761 (2006)
49. Stewart A, "Bone mineral density in osteoarthritis", Curr Opin. Rheumatol, 12, pp.464~467 (2000)
50. Talmo CT, "Nonsurgical management of osteolysis: Challenges and opportunities", Clin Orthop Relat Res, 453, pp.254~264 (2006)
51. Tatu J. Makinen, "The incidence of osteopenia and osteoporosis in women with hip osteoarthritis scheduled for cementless total joint replacement", Bone, 40, pp.1041~1047 (2000)
52. "Professor of Orthopaedics, Ain Shams University Instructional Course Lecture, Ain Shams Arthroclub" (2004)[URL]
53. Venesmaa PK, "Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty: a prospective randomized study", J Bone Miner Res, 16, pp.2126~2131 (2001)
54. Venesmaa PK, "Monitoring of periprosthetic BMD after uncemented total hip arthroplasty with dual-energy X-ray absorptiometry: A 3-year follow-up study", J Bone Miner Res, 16, pp.1056~1061 (2001)
55. von Knoch F, "Effects of bisphosphonates(alendronate and zoledronate) on bone ingrowth in a rabbit model: A radiographic and histomorphometric analysis", Trans Orthop Res Soc, 27, pp.1375~ (2003)
56. Von Knoch F, "Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin", J Biomed Mater Res A, 75, pp.288~294 (2005)
57. Wang X, "Short-term effects of bisphosphonates on the biomechanical properties of canine bone", J Biomed Mater Res, 44, pp.456~460 (1999)
58. Wilkinson JM, "Variation in the TNF gene promoter and risk of osteolysis after total hip arthroplasty", J Bone Miner Res, 18, pp.1995~2001 (2003)
59. 양규현, "High Concentrations of Pamidronate in Bone Weaken the Mechanical Properties of Intact Femora in a Rat Model", Yonsei Medical Journal, 48(4), pp.653~658 (2007), 연세대학교의과대학

관련 논문AI추천